Old Web
English
Sign In
Acemap
>
authorDetail
>
Alyssa R. Kaden
Alyssa R. Kaden
Medicine
Atopic dermatitis
Tachykinin receptor 1
Antagonist
Randomized controlled trial
3
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale based endotypes in atopic dermatitis
2021
Journal of The American Academy of Dermatology
Sandra Smieszek
Bartlomiej P Przychodzen
Sarah E. Welsh
Jennifer L Brzezynski
Alyssa R. Kaden
Michael A Mohrman
Jingyuan Wang
Changfu Xiao
Sonja Ständer
Gunther Birznieks
Christos Polymeropoulos
Mihael H. Polymeropoulos
Show All
Source
Cite
Save
Citations (2)
Neurokinin‐1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: Results from EPIONE, a randomized clinical trial
2021
Journal of The European Academy of Dermatology and Venereology
Sarah E. Welsh
Changfu Xiao
Alyssa R. Kaden
Jennifer L Brzezynski
Michael A Mohrman
Jingyuan Wang
Sandra Smieszek
Bartlomiej P Przychodzen
Sonja Ständer
Christos Polymeropoulos
Gunther Birznieks
Mihael H. Polymeropoulos
Show All
Source
Cite
Save
Citations (6)
27595 Neurokinin-1 receptor antagonist tradipitant improves itch associated with mild atopic dermatitis: Results from EPIONE, a randomized clinical trial
2021
Journal of The American Academy of Dermatology
Jennifer L Brzezynski
Alyssa R. Kaden
Michael A Mohrman
Jingyuan Wang
Sandra P Smieszek
Bartlomiej P Przychodzen
Changfu Xiao
Christos Polymeropoulos
Gunther Birznieks
Mihael H. Polymeropoulos
Show All
Source
Cite
Save
Citations (0)
1